Anbison Lab Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANBISON LAB, and what generic and branded alternatives to ANBISON LAB drugs are available?
ANBISON LAB has four approved drugs.
Summary for Anbison Lab
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 4 |
Drugs and US Patents for Anbison Lab
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anbison Lab | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 207224-002 | Jun 30, 2017 | AB3 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Anbison Lab | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 212948-001 | Sep 30, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Anbison Lab | MONTELUKAST SODIUM | montelukast sodium | TABLET, CHEWABLE;ORAL | 205695-001 | Nov 5, 2015 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Anbison Lab | CARBAMAZEPINE | carbamazepine | TABLET, EXTENDED RELEASE;ORAL | 212948-003 | Sep 30, 2021 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
